{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T11:33:04Z","timestamp":1774438384063,"version":"3.50.1"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/100008196","name":"M\u00e9decins Sans Fronti\u00e8res","doi-asserted-by":"publisher","award":["821562"],"award-info":[{"award-number":["821562"]}],"id":[{"id":"10.13039\/100008196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Malar J"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12936-017-1869-x","type":"journal-article","created":{"date-parts":[[2017,5,23]],"date-time":"2017-05-23T11:42:52Z","timestamp":1495539772000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Intermittent preventive treatment for malaria among children in a refugee camp in Northern Uganda: lessons learned"],"prefix":"10.1186","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3345-5971","authenticated-orcid":false,"given":"Matthew E.","family":"Coldiron","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Estrella","family":"Lasry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malika","family":"Bouhenia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Debashish","family":"Das","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Okui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Nyehangane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juliet","family":"Mwanga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Celine","family":"Langendorf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Greg","family":"Elder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L\u00e9on","family":"Salumu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca F.","family":"Grais","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,5,23]]},"reference":[{"key":"1869_CR1","volume-title":"WHO policy recommendation: seasonal Malaria Chemoprevention for Plasmodium falciparum control in highly seasonal transmission areas of the Sahel sub-region in Africa","author":"WHO Global Malaria Programme","year":"2012","unstructured":"WHO Global Malaria Programme. WHO policy recommendation: seasonal Malaria Chemoprevention for Plasmodium falciparum control in highly seasonal transmission areas of the Sahel sub-region in Africa. Geneva: WHO; 2012."},{"key":"1869_CR2","volume-title":"Policy recommendation on intermittent preventive treatment during infancy with sulphadoxine-pyrimethamine (SP-IPTi) for Plasmodium falciparum malaria control in Africa","author":"WHO","year":"2010","unstructured":"WHO. Policy recommendation on intermittent preventive treatment during infancy with sulphadoxine-pyrimethamine (SP-IPTi) for Plasmodium falciparum malaria control in Africa. Geneva: World Health Organization; 2010."},{"key":"1869_CR3","volume-title":"Updated policy recommendation: intermittent preventive treatment of malaria in pregnancy using sulfadoxine-pyrimethamine (IPTp-SP)","author":"World Health Organization","year":"2012","unstructured":"World Health Organization. Updated policy recommendation: intermittent preventive treatment of malaria in pregnancy using sulfadoxine-pyrimethamine (IPTp-SP). Geneva: World Health Organization; 2012."},{"key":"1869_CR4","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1093\/cid\/ciu150","volume":"58","author":"JI Nankabirwa","year":"2014","unstructured":"Nankabirwa JI, Wandera B, Amuge P, Kiwanuka N, Dorsey G, Rosenthal PJ, et al. Impact of intermittent preventive treatment with dihydroartemisinin-piperaquine on malaria in Ugandan schoolchildren: a randomized, placebo-controlled trial. Clin Infect Dis. 2014;58:1404\u201312.","journal-title":"Clin Infect Dis"},{"key":"1869_CR5","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1752-1505-5-17","volume":"5","author":"J Anderson","year":"2011","unstructured":"Anderson J, Doocy S, Haskew C, Spiegel P, Moss WJ. The burden of malaria in post-emergency refugee sites: a retrospective study. Confl Health. 2011;5:17.","journal-title":"Confl Health"},{"key":"1869_CR6","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1186\/s12936-016-1479-z","volume":"15","author":"R Charchuk","year":"2016","unstructured":"Charchuk R, Makelele KJP, Kasereka MC, Houston S, Hawkes MT. Burden of malaria is higher among children in an internal displacement camp compared to a neighbouring village in the Democratic Republic of the Congo. Malar J. 2016;15:431.","journal-title":"Malar J"},{"key":"1869_CR7","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1128\/AAC.05877-11","volume":"56","author":"KM Lwin","year":"2012","unstructured":"Lwin KM, Phyo AP, Tarning J, Hanpithakpong W, Ashley EA, Lee SJ, et al. Randomized, double-blind, placebo-controlled trial of monthly versus bimonthly dihydroartemisinin-piperaquine chemoprevention in adults at high risk of malaria. Antimicrob Agents Chemother. 2012;56:1571\u20137.","journal-title":"Antimicrob Agents Chemother"},{"key":"1869_CR8","unstructured":"United Nations High Commissioner for Refugees. South Sudan situation-regional overview."},{"key":"1869_CR9","volume-title":"ICF International. Uganda malaria indicator survey 2014\u20132015","author":"Uganda Bureau of Statistics","year":"2015","unstructured":"Uganda Bureau of Statistics. ICF International. Uganda malaria indicator survey 2014\u20132015. Kampala: Uganda Bureau of Statistics; 2015."},{"key":"1869_CR10","volume-title":"Basic malaria microscopy-2nd edition learner\u2019s guide","author":"WHO","year":"2010","unstructured":"WHO. Basic malaria microscopy-2nd edition learner\u2019s guide. Geneva: World Health Organization; 2010."},{"key":"1869_CR11","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1186\/1475-2875-12-325","volume":"12","author":"EN Allen","year":"2013","unstructured":"Allen EN, Chandler CI, Mandimika N, Pace C, Mehta U, Barnes KI. Evaluating harm associated with anti-malarial drugs: a survey of methods used by clinical researchers to elicit, assess and record participant-reported adverse events and related data. Malar J. 2013;12:325.","journal-title":"Malar J"},{"key":"1869_CR12","volume-title":"Management of safety information from clinical trials","author":"CIOMS","year":"2005","unstructured":"CIOMS. Management of safety information from clinical trials. Geneva: Council for International Organizations of Medical Sciences; 2005."},{"key":"1869_CR13","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1586\/ecp.10.37","volume":"3","author":"U Mehta","year":"2010","unstructured":"Mehta U, Allen E, Barnes KI. Establishing pharmacovigilance programs in resource-limited settings: the example of treating malaria. Expert Rev Clin Pharmacol. 2010;3:509\u201325.","journal-title":"Expert Rev Clin Pharmacol."},{"key":"1869_CR14","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1186\/1475-2875-12-374","volume":"12","author":"H Pasquale","year":"2013","unstructured":"Pasquale H, Jarvese M, Julla A, Doggale C, Sebit B, Lual MY, et al. Malaria control in South Sudan, 2006\u20132013: strategies, progress and challenges. Malar J. 2013;12:374.","journal-title":"Malar J."},{"key":"1869_CR15","first-page":"1","volume":"10","author":"WorldWide Antimalarial Resistance Network (WWARN)\u00a0DP\u00a0Study Group","year":"2013","unstructured":"WorldWide Antimalarial Resistance Network (WWARN)\u00a0DP\u00a0Study Group. The effect of dosing regimens on the antimalarial efficacy of dihydroartemisinin-piperaquine: a pooled analysis of individual patient data. PLoS Med. 2013;10:1\u201317.","journal-title":"PLoS Med"}],"container-title":["Malaria Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-017-1869-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,5,23]],"date-time":"2017-05-23T11:43:10Z","timestamp":1495539790000},"score":1,"resource":{"primary":{"URL":"http:\/\/malariajournal.biomedcentral.com\/articles\/10.1186\/s12936-017-1869-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,23]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["1869"],"URL":"https:\/\/doi.org\/10.1186\/s12936-017-1869-x","relation":{},"ISSN":["1475-2875"],"issn-type":[{"value":"1475-2875","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,23]]},"article-number":"218"}}